IBEX (NASDAQ:IBEX - Get Free Report) is projected to post its quarterly earnings results after the market closes on Thursday, February 6th. Analysts expect IBEX to post earnings of $0.49 per share and revenue of $134.63 million for the quarter. IBEX has set its FY 2025 guidance at EPS.Individual that are interested in participating in the company's earnings conference call can do so using this link.
IBEX (NASDAQ:IBEX - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.48 EPS for the quarter. IBEX had a net margin of 6.57% and a return on equity of 22.54%. The company had revenue of $129.72 million during the quarter.
IBEX Stock Performance
Shares of IBEX traded down $0.23 during mid-day trading on Thursday, hitting $22.09. 105,560 shares of the company were exchanged, compared to its average volume of 126,108. The stock has a market cap of $370.34 million, a price-to-earnings ratio of 11.69 and a beta of 0.78. IBEX has a 1-year low of $13.00 and a 1-year high of $22.67. The company has a 50 day moving average of $21.05 and a 200-day moving average of $19.10.
Analyst Ratings Changes
Separately, Robert W. Baird raised their target price on IBEX from $23.00 to $26.00 and gave the company an "outperform" rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $21.25.
Get Our Latest Stock Report on IBEX
Insiders Place Their Bets
In other IBEX news, CEO Robert Thomas Dechant sold 1,792 shares of the business's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $22.50, for a total value of $40,320.00. Following the transaction, the chief executive officer now directly owns 226,841 shares in the company, valued at $5,103,922.50. The trade was a 0.78 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder Gem G.P. L.P. Pinebridge II sold 78,728 shares of the firm's stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $20.12, for a total transaction of $1,584,007.36. Following the sale, the insider now owns 1,641,011 shares of the company's stock, valued at $33,017,141.32. This represents a 4.58 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 327,694 shares of company stock valued at $6,653,798 in the last ninety days. 6.72% of the stock is currently owned by corporate insiders.
About IBEX
(
Get Free Report)
IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company products and services portfolio includes ibex Connect, that offers customer service, technical support, revenue generation, and other revenue generation outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that comprises digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience.
Further Reading
Before you consider IBEX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IBEX wasn't on the list.
While IBEX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.